JP Morgan Maintains Overweight on Biohaven, Raises Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Tessa Romero has maintained an Overweight rating on Biohaven (NYSE:BHVN) and raised the price target from $55 to $68.
October 03, 2024 | 3:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan has increased its price target for Biohaven from $55 to $68, maintaining an Overweight rating. This suggests confidence in Biohaven's future performance.
The increase in price target from $55 to $68 by JP Morgan indicates a positive outlook on Biohaven's stock, likely leading to a short-term price increase. The Overweight rating suggests that the analyst expects the stock to outperform the average total return of stocks in the analyst's coverage universe.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100